Vinorelbine-based chemotherapy in hormone-refractory prostate cancer.
Zampino MG, Verri E, Locatelli M, Curigliano G, Ascione G, Sbanotto A, Rocca A, Verweij F, Matei V, Scardino E, Decobelli O, Goldhirsch A, Nolè F.
Zampino MG, et al. Among authors: rocca a.
Anticancer Res. 2006 May-Jun;26(3B):2375-80.
Anticancer Res. 2006.
PMID: 16821619
Free article.
Clinical Trial.